This inventor holds 3 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2011-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gotenba, JP (2011)
- Shizuoka, JP (2016 - 2019)
Company Filing History:
Years Active: 2011-2019
Title: Kazutaka Yoshihashi: Innovator in Bispecific Antibodies
Introduction
Kazutaka Yoshihashi is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. With a total of 3 patents to his name, Yoshihashi is recognized for his innovative approaches to treating blood coagulation disorders.
Latest Patents
Yoshihashi's latest patents focus on methods of treatment that involve the administration of bispecific antibodies. These antibodies specifically bind to both blood coagulation factor IX/activated blood coagulation factor IX and blood coagulation factor X. They functionally substitute for the cofactor function of blood coagulation factor VIII, promoting the activation of blood coagulation factor X by activated blood coagulation factor IX. From these antibodies, multispecific antigen-binding molecules with high activity in functionally substituting for blood coagulation factor VIII have been successfully discovered.
Career Highlights
Kazutaka Yoshihashi is currently employed at Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work has been instrumental in advancing therapeutic options for patients with coagulation disorders. His innovative research has garnered attention in the scientific community, contributing to the understanding of blood coagulation mechanisms.
Collaborations
Yoshihashi has collaborated with notable colleagues, including Takehisa Kitazawa and Tomoyuki Igawa. These partnerships have enhanced the research and development of bispecific antibodies, leading to breakthroughs in treatment methodologies.
Conclusion
Kazutaka Yoshihashi's contributions to the field of biomedicine through his patents on bispecific antibodies highlight his role as an innovator. His work continues to pave the way for advancements in the treatment of blood coagulation disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile